The state of Alaska received $2 million in an antitrust settlement in which a pharmaceutical company was accused of monopolizing the rights to a lifesaving drug in order to maintain massive price hikes.
The $100 million settlement was filed Jan. 18 in US District Court for the District of Columbia. Alaska, Maryland, New York, Texas and Washington joined the Federal Trade Commission in the complaint against Mallinckrodt Ard, formerly known as Questcor Pharmaceuticals.
The settlement arose around antitrust allegations regarding a type of drug used to treat life-threatening maladies, including infantile spasms and nephritic syndrome.
In 2001, Questcor bought the rights to the drug Acthar for $100,000 and “modest royalties,” the complaint says. Acthar, derived from pigs’ pituitary glands, is an adrenocorticotropic hormone-based therapeutic drug.
At the time, the drug cost $40 per vial. Quesctor went on to raise the price to more than $34,000 per vial — an 85,000 percent increase, the complaint says.
Full Content: ADN
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Geradin Partners Expands Paris Office with Key Hire
Aug 30, 2024 by
CPI
Judge Accuses Google of ‘Clear Abuse’ in Antitrust Case Over Deleted Employee Chats
Aug 29, 2024 by
CPI
Hong Kong Cleaning Company Employee Charged in Historic Antitrust Investigation Case
Aug 29, 2024 by
CPI
Inside the Yelp Suit: Allegations of Google’s Abuse of Search Power
Aug 29, 2024 by
CPI
AI Safety Bill Clears Hurdle in California, Heads to Governor’s Desk
Aug 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – State Attorneys General
Aug 22, 2024 by
CPI
CPI Talks… …With Attorney General Phil Weiser
Aug 22, 2024 by
CPI
The Bipartisan Miracle of State Antitrust Enforcement
Aug 22, 2024 by
Gwendolyn J. Lindsay Cooley
Recent Developments in State Antitrust Enforcement: Agriculture and Food Markets
Aug 22, 2024 by
Elizabeth R. Odette
State Attorneys General: Stewards of Consumer Health and Welfare
Aug 22, 2024 by
Brooke Howlett Lovrovich